Ebola Still An 'urgent' Global Health Emergency: WHO
DRC's latest Ebola epidemic, which began in August 2018, has killed 2,144 people, making it the second deadliest outbreak of the virus, after the West Africa pandemic of 2014-2016.
Photo: AFP
Geneva: The deadly Ebola epidemic in the Democratic Republic of Congo (DRC) remains an "urgent" global health emergency, The World Health Organization (WHO) said Friday at its Emergency Committee meeting.
DRC's latest Ebola epidemic, which began in August 2018, has killed 2,144 people, making it the second deadliest outbreak of the virus, after the West Africa pandemic of 2014-2016.
"The public health emergency will be maintained for an additional three months", WHO director-general Tedros Adhanom Ghebreyesus said at a press conference.
"This outbreak remains a complex and dangerous outbreak," he said, deploring the lack of funding.
The status of a global health emergency is an exceptional measure that has been used by the WHO four times: in 2009 for the Swine flu virus, in 2014 for polio, in 2014 for the Ebola epidemic which killed more than 11,000 in Liberia, Guinea, Sierra Leone and in 2016 for the Zika virus.
Last week, the director of the WHO Emergency Program, Michael Ryan, expressed "cautious optimism" that the epidemic was confined to a smaller region.
The DRC health ministry said earlier this week Ebola had returned to Ituri province in the north-east of the country after nearly 300 days without any new cases.
"The number of cases has declined each week for the past four weeks. But these encouraging trends should be interpreted with caution," Adhanom Ghebreyesus said.
"The area is a very complex area, it's a very volatile area. We have made very significant progress, the number of cases have plummeted.
"But if there is insecurity incidents, we may lose what we have gained so far."
Since the most recent Ebola outbreak, a vaccine a developed by Merck Sharp and Dohme has been used on more than 230,000 people.
On Friday, the vaccine which has yet to be licensed, received a green light from The European Medicines Agency (EMA) in a step towards its commercialisation.
A second experimental vaccine manufactured by the Belgian subsidiary of Johnson & Johnson is to be introduced in November, according to DR Congo medical officials.
-
What do scientists hope to learn from total solar eclipse in US?
2024-03-28 -
Song lyrics are getting simpler, more repetitive: study
2024-03-28 -
German court rules against Mercedes in emissions case
2024-03-28 -
UK greenhouse gas emissions fell 5.4 percent in 2023: data
2024-03-28 -
French film grooming claims puts focus on child coaches
2024-03-28 -
George Washington University faces $10mn disinformation lawsuit
2024-03-28 -
Climate change is messing with how we measure time: study
2024-03-28 -
Struggling for a can of food: starving Gazans scramble for aid drops
2024-03-26 -
Pandemic accord talks at loggerheads as time ticks away
2024-03-26 -
Racism reducing my desire to play football: Brazil's Vinicius
2024-03-25